arrow
Back
A

Andrew L. Frelinger

childrens hospital of philadelphia

55H-index
221Paper Count
1.2WCitation Count
Published Papers 73
Publication Date
The association between immature platelet count and clinical characteristics in pediatric immune thrombocytopenia
err2026-04-01
err0
errOAAI
errHarris, Emily M.; Lambert, Michele P.; Grimes, Amanda; Despotovic, Jenny; Rothman, Jennifer A.; McComb, Caitlyn; Guedes, Brian; Kirk, Susan; Arulselvan, Abinaya; Basara, Matthew; Cannon, Brenna; King, Sam; Frelinger, Andrew L.; Chen, Nan; London, Wendy B.; Grace, Rachael F.
errShare
errSave
Clinical and Research Methods for Analysis and Study of Platelet Populations
errBlood
IF23.1
err2025-10-10
err0
PREAI
errThomas Thiele; Johan W. M. Heemskerk; Andrew L. Frelinger
errShare
errSave
A minimum valency of four is required for robust activation of platelets in flow cytometry by multivalent nanobodies to GPVI, CLEC-2 and PEAR1
err2025-09-24
err0
errOAAI
errRachel E. Lamerton; Eleyna M. Martin; Jacqueline Perry; Adam F. Cunningham; Steve P. Watson; Andrew L. Frelinger
errShare
errSave
Platelet Pathophysiology: Unexpected New Research Directions
err2024-06-18
err2
PREAI
errMichelson, Alan D.; Frelinger, Andrew L.; Haynes, Robin L.; Kinney, Hannah C.; Gremmel, Thomas
errShare
errSave
Dysregulation of platelet serotonin, 14-3-3, and GPIX in sudden infant death syndrome
err2024-05-15
err1
errOAAI
errFrelinger, Andrew L., III; Haynes, Robin L.; Goldstein, Richard D.; Berny-Lang, Michelle A.; Gerrits, Anja J.; Riehs, Molly; Haas, Elisabeth A.; Paunovic, Brankica; Mena, Othon J.; Campman, Steven C.; Milne, Ginger L.; Sleeper, Lynn A.; Kinney, Hannah C.; Michelson, Alan D.
errShare
errSave
Platelet Physiology
err2024-04-23
err6
PREAI
errGremmel, Thomas; Frelinger, I. I. I. Andrew L.; Michelson, Alan D.
errShare
errSave
Expert opinion on the use of platelet secretion assay for the diagnosis of inherited platelet function disorders: Communication from the ISTH SSC Subcommittee on Platelet Physiology
err2022-09-01
err11
errOAAI
errMezzano, Diego; Harrison, Paul; Frelinger, Andrew L., III; Mumford, Andrew D.; Noris, Patrizia; Lordkipanidze, Marie; Gresele, Paolo
errShare
errSave
Inhibition of transcription factor NFAT activity in activated platelets enhances their aggregation and exacerbates gram-negative bacterial septicemia
errIMMUNITY
IF26.3
err2022-02-01
err17
errOAAI
errPoli, Valentina; Di Gioia, Marco; Sola-Visner, Martha; Granucci, Francesca; Frelinger, Andrew L.; Michelson, Alan D.; Zanoni, Ivan
errShare
errSave
Sex-specific platelet activation through protease-activated receptor-1 in patients undergoing cardiac catheterization
err2021-12-01
err4
errOAAI
errGremmel, Thomas; Michelson, Alan D.; Wadowski, Patricia P.; Pultar, Joseph; Weikert, Constantin; Tscharre, Maximilian; Lee, Silvia; Panzer, Simon; Frelinger, Andrew L.
errShare
errSave
Consensus recommendations on flow cytometry for the assessment of inherited and acquired disorders of platelet number and function: Communication from the ISTH SSC Subcommittee on Platelet Physiology
err2021-12-01
err29
errOAAI
errFrelinger, Andrew L., III; Rivera, Jose; Connor, David E.; Freson, Kathleen; Greinacher, Andreas; Harrison, Paul; Kunishima, Shinji; Lordkipanidze, Marie; Michelson, Alan D.; Ramstrom, Sofia; Gresele, Paolo
errShare
errSave
Platelet Activation and Reactivity in a Large Cohort of Patients with Gaucher Disease
err2021-11-05
err5
PREAI
errRevel-Vilk, Shoshana; Naamad, Mira; Frydman, Dafna; Freund, Michael R.; Dinur, Tama; Istaiti, Majdolen; Becker-Cohen, Michal; Falk, Roni; Broide, Eti; Michelson, Alan D.; Frelinger, Andrew L., III; Zimran, Ari
errShare
errSave
errShare
errSave
An exploratory, randomised, placebo-controlled, 14 day trial of the soluble guanylate cyclase stimulator praliciguat in participants with type 2 diabetes and hypertension
err2019-12-19
err23
errOAAI
errHanrahan, John P.; Seferovic, Jelena P.; Wakefield, James D.; Wilson, Phebe J.; Chickering, Jennifer G.; Jung, Joon; Carlson, Kenneth E.; Zimmer, Daniel P.; Frelinger, Andrew L., III; Michelson, Alan D.; Morrow, Linda; Hall, Michael; Currie, Mark G.; Milne, G. Todd; Profy, Albert T.
errShare
errSave
PF-04447943, a Phosphodiesterase 9A Inhibitor, in Stable Sickle Cell Disease Patients: A Phase Ib Randomized, Placebo-Controlled Study
err2018-12-31
err24
errOAAI
errCharnigo, Robert J.; Beidler, David; Rybin, Denis; Pittman, Debra D.; Tan, Beesan; Howard, Jo; Michelson, Alan D.; Frelinger, Andrew L., III; Clarke, Nicholas
errShare
errSave
Avatrombopag increases platelet count but not platelet activation in patients with thrombocytopenia resulting from liver disease
err2018-12-01
err30
errOAAI
errMichelson, A. D.; Koganov, E. Smolensky; Forde, E. E.; Carmichael, S. L.; Frelinger, A. L., III
errShare
errSave
GLS-409, an Antagonist of Both P2Y1 and P2Y12, Potently Inhibits Canine Coronary Artery Thrombosis and Reversibly Inhibits Human Platelet Activation (vol 8, 17580, 2018)
err2018-11-29
err1
errOAAI
errKoganov, Elena Smolensky; Michelson, Alan D.; Yanachkov, Ivan B.; Yanachkova, Milka I.; Wright, George E.; Przyklenk, Karin; Frelinger, Andrew L., III
errShare
errSave
Laboratory monitoring of P2Y12 inhibitors: communication from the SSC of the ISTH
err2018-11-01
err15
errOAAI
errFrelinger, A. L., III; Gachet, C.; Mumford, A. D.; Noris, P.; Mezzano, D.; Harrison, P.; Gresele, P.
errShare
errSave
GLS-409, an Antagonist of Both P2Y1 and P2Y12, Potently Inhibits Canine Coronary Artery Thrombosis and Reversibly Inhibits Human Platelet Activation
err2018-09-28
err6
errOAAI
errKoganov, Elena Smolensky; Michelson, Alan D.; Yanachkov, Ivan B.; Yanachkova, Milka I.; Wright, George E.; Przyklenk, Karin; Frelinger, Andrew L., III
errShare
errSave
Novel aspects of antiplatelet therapy in cardiovascular disease
err2018-07-01
err39
errOAAI
errGremmel, Thomas; Michelson, Alan D.; Frelinger, Andrew L., III; Bhatt, Deepak L.
errShare
errSave